Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Chiara

Showing results (21-30 of 62) with videos related to

Pageof 7
Sort By:
American Journal of Clinical Oncology|June 19, 2001
Gemcitabine in advanced pancreatic cancer: a phase II trialL Crinò, A M Mosconi, C Calandri, et al.
Gynecologic Oncology|April 1, 1993
Cerebral metastases secondary to ovarian cancer: still an unusual eventM Bruzzone, E Campora, S Chiara, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Prediction of survival by thymidine labelling index in patients with resistant ovarian carcinomaA Alama, F Merlo, S Chiara, et al.
European Journal of Cancer (Oxford, England : 1990)|May 1, 1997
Hand-foot syndrome induced by high-dose, short-term, continuous 5-fluorouracil infusionS Chiara, M T Nobile, C Barzacchi, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|November 1, 1991
Abdominopelvic radiotherapy following surgery and chemotherapy in advanced ovarian cancerS Chiara, M Orsatti, P Franzone, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Tumour kinetics, response to chemotherapy and survival in primary ovarian cancerA Alama, S Chiara, F Merlo, et al.
Chemioterapia : International Journal of the Mediterranean Society of Chemotherapy|April 1, 1985
High dose cisplatin after failure of polychemotherapy containing cisplatin in ovarian cancer. Preliminary resultsM Bruzzone, P F Conte, S Chiara, et al.
Giornale Italiano Di Chemioterapia|January 1, 1985
[Adjuvant chemotherapy with cisplatin and cyclophosphamide in FIGO I-II epithelial carcinoma of the ovary: preliminary results]S Chiara, P F Conte, M Bruzzone, et al.
Gynecologic Oncology|September 1, 1990
Chemotherapy versus radiotherapy in the management of ovarian cancer patients with pathological complete response or minimal residual disease at second lookM Bruzzone, L Repetto, S Chiara, et al.
Tumori|June 30, 1990
Prognostic factors in stage IV ovarian carcinoma treated with platinum-based regimensL Repetto, S Chiara, M Pace, et al.
Pageof 7

Showing results (21-30 of 62) with videos related to

Sort By:
Pageof 7
American Journal of Clinical Oncology|June 19, 2001
Gemcitabine in advanced pancreatic cancer: a phase II trialL Crinò, A M Mosconi, C Calandri, et al.
Gynecologic Oncology|April 1, 1993
Cerebral metastases secondary to ovarian cancer: still an unusual eventM Bruzzone, E Campora, S Chiara, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Prediction of survival by thymidine labelling index in patients with resistant ovarian carcinomaA Alama, F Merlo, S Chiara, et al.
European Journal of Cancer (Oxford, England : 1990)|May 1, 1997
Hand-foot syndrome induced by high-dose, short-term, continuous 5-fluorouracil infusionS Chiara, M T Nobile, C Barzacchi, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|November 1, 1991
Abdominopelvic radiotherapy following surgery and chemotherapy in advanced ovarian cancerS Chiara, M Orsatti, P Franzone, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Tumour kinetics, response to chemotherapy and survival in primary ovarian cancerA Alama, S Chiara, F Merlo, et al.
Chemioterapia : International Journal of the Mediterranean Society of Chemotherapy|April 1, 1985
High dose cisplatin after failure of polychemotherapy containing cisplatin in ovarian cancer. Preliminary resultsM Bruzzone, P F Conte, S Chiara, et al.
Giornale Italiano Di Chemioterapia|January 1, 1985
[Adjuvant chemotherapy with cisplatin and cyclophosphamide in FIGO I-II epithelial carcinoma of the ovary: preliminary results]S Chiara, P F Conte, M Bruzzone, et al.
Gynecologic Oncology|September 1, 1990
Chemotherapy versus radiotherapy in the management of ovarian cancer patients with pathological complete response or minimal residual disease at second lookM Bruzzone, L Repetto, S Chiara, et al.
Tumori|June 30, 1990
Prognostic factors in stage IV ovarian carcinoma treated with platinum-based regimensL Repetto, S Chiara, M Pace, et al.
Pageof 7